Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
China Chemical & Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$21.75 |
52 Week High | NT$28.00 |
52 Week Low | NT$21.35 |
Beta | 0.13 |
1 Month Change | -3.97% |
3 Month Change | -6.05% |
1 Year Change | -19.74% |
3 Year Change | -9.75% |
5 Year Change | 15.38% |
Change since IPO | -36.84% |
Recent News & Updates
Recent updates
Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching
Apr 25We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On
Mar 17China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 24Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?
Jan 27Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On
Dec 16China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 26Shareholder Returns
1701 | TW Pharmaceuticals | TW Market | |
---|---|---|---|
7D | -5.6% | -1.0% | -3.7% |
1Y | -19.7% | 10.0% | 24.4% |
Return vs Industry: 1701 underperformed the TW Pharmaceuticals industry which returned 10% over the past year.
Return vs Market: 1701 underperformed the TW Market which returned 24.4% over the past year.
Price Volatility
1701 volatility | |
---|---|
1701 Average Weekly Movement | 2.1% |
Pharmaceuticals Industry Average Movement | 3.8% |
Market Average Movement | 4.5% |
10% most volatile stocks in TW Market | 8.3% |
10% least volatile stocks in TW Market | 2.0% |
Stable Share Price: 1701 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1701's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1952 | n/a | Chih-Yung Wu | www.ccpc.com.tw |
China Chemical & Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. The company provides sexual function supplements; cardiovascular drugs, anti-lipidemia drugs, and peripheral circulation impediment relieving agents; diabetes treatment drugs, adrenocortico steroids, and weight control drugs; and anti-infection drugs, such as antibiotics, antifungal drugs, and anti-viral drugs.
China Chemical & Pharmaceutical Co., Ltd. Fundamentals Summary
1701 fundamental statistics | |
---|---|
Market cap | NT$6.38b |
Earnings (TTM) | NT$322.29m |
Revenue (TTM) | NT$8.57b |
20.1x
P/E Ratio0.8x
P/S RatioIs 1701 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1701 income statement (TTM) | |
---|---|
Revenue | NT$8.57b |
Cost of Revenue | NT$5.43b |
Gross Profit | NT$3.14b |
Other Expenses | NT$2.82b |
Earnings | NT$322.29m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.08 |
Gross Margin | 36.62% |
Net Profit Margin | 3.76% |
Debt/Equity Ratio | 41.2% |
How did 1701 perform over the long term?
See historical performance and comparison